UK markets closed

KALA BIO, Inc. (0JQ2.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
6.84-0.43 (-5.88%)
At close: 04:19PM BST
Full screen
Previous close7.26
Open6.71
BidN/A x N/A
AskN/A x N/A
Day's range6.71 - 6.84
52-week range5.27 - 19.48
Volume505
Avg. volume320
Market capN/A
Beta (5Y monthly)-2.04
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date02 Aug 2024 - 06 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    KALA BIO Announces $12,500,000 Private Placement

    ARLINGTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors for the sale, in a private placement, of shares of its common stock and shares of its Series H Convertible Non-Redeema

  • GlobeNewswire

    KALA BIO to Present at Jefferies Global Healthcare Conference

    ARLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that Kim Brazzell, Ph.D., Head of R&D and Chief Medical Officer of KALA BIO, will present at the Jefferies Global Healthcare Conference being held in New York, NY on Wednesday, June 5, 2024 at 12:30 p.m. ET. Management will also be av

  • Insider Monkey

    Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)

    European stocks started the day on May 21 with a slightly weaker note, marking a retreat from their recent impressive performance, with attention now shifting towards the upcoming earnings report from NVIDIA. The Stoxx 600 index dipped by 0.2%, showing a predominantly negative trend across most sectors, while futures for US equities remained relatively unchanged. […]